| (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointe | Phase III | rekrutiert |
| - IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite S | Phase II | rekrutiert |
| 177Lu-DOTATATE for Recurrent Meningioma | Phase II | rekrutiert |
| A Clinical Study of Arfolitixorin in Patients With mCRC | Phase I / Phase II | rekrutiert |
| A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With C | Phase III | rekrutiert |
| A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melano | Phase II | rekrutiert |
| A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients Wi | Phase III | rekrutiert |
| A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity | Phase III | rekrutiert |
| A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity | Phase III | rekrutiert |
| A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially B | Phase I / Phase II | rekrutiert |
| A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibros | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment | Phase III | rekrutiert |
| A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head | Phase III | rekrutiert |
| A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradi | Phase III | rekrutiert |
| A Long-term Extension Study of PCI-32765 (Ibrutinib) | Phase III | rekrutiert |
| A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and You | Phase II | rekrutiert |
| A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on | Phase II | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutati | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Non-interventional, Prospective Study With Benralizumab | — | rekrutiert |
| A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma | Phase II | rekrutiert |
| A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Prev | Phase III | rekrutiert |
| A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart | Phase III | rekrutiert |
| A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo | Phase III | rekrutiert |
| A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Sa | Phase III | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of | Phase III | rekrutiert |
| A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Pl | Phase III | rekrutiert |
| A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and | Phase III | rekrutiert |
| A Phase IIb Study to Evaluate AZD8965 in Participants With IPF. | Phase II | rekrutiert |
| A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in | Phase I / Phase II | rekrutiert |
| A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan | Phase III | rekrutiert |
| A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoc | Phase III | rekrutiert |
| A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System:T | — | rekrutiert |
| A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglob | — | rekrutiert |
| A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in Pe | Phase II | rekrutiert |
| A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function | Phase II | rekrutiert |
| A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in | Phase II | rekrutiert |
| A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart | Phase III | rekrutiert |
| A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to | Phase IV | rekrutiert |
| A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar | Phase III | rekrutiert |
| A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD | Phase I / Phase II | rekrutiert |
| A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD | Phase III | rekrutiert |
| A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carbopla | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab a | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With M | Phase I / Phase II | rekrutiert |
| A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Do | Phase III | rekrutiert |
| A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head | Phase I / Phase II | rekrutiert |
| A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First | Phase III | rekrutiert |
| A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in P | Phase III | rekrutiert |
| A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian C | Phase III | rekrutiert |
| A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic | Phase III | rekrutiert |
| A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced So | Phase I / Phase II | rekrutiert |
| A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Canc | — | rekrutiert |
| A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer | Phase I / Phase II | rekrutiert |
| A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanc | Phase III | rekrutiert |
| A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory | Phase III | rekrutiert |
| A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With General | Phase II / Phase III | rekrutiert |
| A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early | Phase III | rekrutiert |
| A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabe | Phase III | rekrutiert |
| A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 D | Phase III | rekrutiert |
| A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or | Phase III | rekrutiert |
| A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stro | Phase III | rekrutiert |
| A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapse | Phase III | rekrutiert |
| A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) | Phase II | rekrutiert |
| A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated | Phase II / Phase III | rekrutiert |
| A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neop | Phase I | rekrutiert |
| A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose | Phase II | rekrutiert |
| A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors | Phase I | rekrutiert |
| A Study of LY4257496 in Participants With Cancer (OMNIRAY) | Phase I | rekrutiert |
| A Study of LY4337713 in Participants With FAP-Positive Solid Tumors | Phase I | rekrutiert |
| A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers | Phase I | rekrutiert |
| A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men | Phase III | rekrutiert |
| A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer | Phase II | rekrutiert |
| A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Ca | Phase III | rekrutiert |
| A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cance | Phase III | rekrutiert |
| A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration | Phase III | rekrutiert |
| A Study of Pitolisant in Patients With Prader-Willi Syndrome | Phase III | rekrutiert |
| A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide | Phase I | rekrutiert |
| A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovaria | Phase II / Phase III | rekrutiert |
| A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or L | Phase II | rekrutiert |
| A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NP | Phase I / Phase II | rekrutiert |
| A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tra | Phase III | rekrutiert |
| A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembroliz | Phase III | rekrutiert |
| A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pem | Phase III | rekrutiert |
| A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab | Phase III | rekrutiert |
| A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With | Phase III | rekrutiert |
| A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoP | — | rekrutiert |
| A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract | Phase III | rekrutiert |
| A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemot | Phase III | rekrutiert |
| A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Canc | Phase III | rekrutiert |
| A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRI | Phase II | rekrutiert |
| A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associa | Phase III | rekrutiert |
| A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy | Phase II | rekrutiert |
| A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refr | Phase I / Phase II | rekrutiert |
| A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Trea | — | rekrutiert |
| A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary | Phase III | rekrutiert |
| A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Aga | Phase III | rekrutiert |
| A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemothe | Phase II / Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of The | Phase III | rekrutiert |
| A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab P | Phase III | rekrutiert |
| A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus | Phase III | rekrutiert |
| A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Mo | Phase II | rekrutiert |
| A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-M | Phase III | rekrutiert |
| A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 | Phase III | rekrutiert |
| A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migrai | Phase II | rekrutiert |
| A Study to Evaluate Safety and Efficacy of Subcutaneous Administration of Anakinra in Patients W | Phase II | rekrutiert |
| A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplan | Phase III | rekrutiert |
| A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abe | Phase I / Phase II | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab Wit | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previous | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Mul | Phase II | rekrutiert |
| A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Y | Phase II | rekrutiert |
| A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive | Phase III | rekrutiert |
| A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferati | Phase I | rekrutiert |
| A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx | Phase I | rekrutiert |
| A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic P | Phase II | rekrutiert |
| A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by | Phase III | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies | Phase IV | rekrutiert |
| A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Par | Phase III | rekrutiert |
| A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared | Phase III | rekrutiert |
| A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Grave | Phase II | rekrutiert |
| A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared | Phase III | rekrutiert |
| A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sep | Phase II | rekrutiert |
| A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Particip | Phase II | rekrutiert |
| A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult | Phase III | rekrutiert |
| A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Tak | Phase III | rekrutiert |
| A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standar | Phase III | rekrutiert |
| A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How i | Phase III | rekrutiert |
| A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 | Phase II | rekrutiert |
| A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Ca | Phase II | rekrutiert |
| A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Fa | Phase III | rekrutiert |
| A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseas | Phase III | rekrutiert |
| A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosu | Phase III | rekrutiert |
| A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenou | Phase III | rekrutiert |
| A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part | Phase III | rekrutiert |
| ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional A | Phase III | rekrutiert |
| AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or | Phase I | rekrutiert |
| AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer. | ohne Phasenangabe | rekrutiert |
| AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple My | Phase I / Phase II | rekrutiert |
| AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia | Phase I / Phase II | rekrutiert |
| AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate | Phase III | rekrutiert |
| AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platin | Phase III | rekrutiert |
| Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL | Phase III | rekrutiert |
| Adaptive Radiotherapy in Head and Neck Tumor Patients | ohne Phasenangabe | rekrutiert |
| Adaptive Radiotherapy in Patients With Gynecological Tumors | ohne Phasenangabe | rekrutiert |
| Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At | Phase II | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leuka | Phase II / Phase III | rekrutiert |
| An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients Wi | ohne Phasenangabe | rekrutiert |
| An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical | — | rekrutiert |
| An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-ter | Phase III | rekrutiert |
| An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA | Phase III | rekrutiert |
| An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaem | Phase III | rekrutiert |
| An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing | Phase I / Phase II | rekrutiert |
| Anifrolumab Malignancy and Serious Infections Study | — | rekrutiert |
| Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection | Phase I / Phase II | rekrutiert |
| Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke | Phase III | rekrutiert |
| Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipopr | Phase III | rekrutiert |
| Atypical Hemolytic-Uremic Syndrome (aHUS) Registry | — | rekrutiert |
| Audio Hypnosis for Reducing Anxiety in Children and Adolescents Undergoing MRI: A Randomized Con | ohne Phasenangabe | rekrutiert |
| BENTO - Bronchoscopic Lung Volume Reduction in Severe Emphysema Using Thermoablation | ohne Phasenangabe | rekrutiert |
| BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatmen | — | rekrutiert |
| Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination Wit | Phase I / Phase II | rekrutiert |
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | — | rekrutiert |
| Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET) | — | rekrutiert |
| CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer | — | rekrutiert |
| COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer | — | rekrutiert |
| COMS for Chronic Ulcers Treatment | Phase IV | rekrutiert |
| CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting | — | rekrutiert |
| Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello- | Phase III | rekrutiert |
| Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer | Phase II | rekrutiert |
| Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease | — | rekrutiert |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | — | rekrutiert |
| Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute My | Phase I / Phase II | rekrutiert |
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lym | Phase II | rekrutiert |
| Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Ol | Phase II | rekrutiert |
| Comparison of Vessel-FFR Versus FFR in Intermediate Coronary Stenoses | ohne Phasenangabe | rekrutiert |
| Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women | ohne Phasenangabe | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Re | Phase IV | rekrutiert |
| Cyclosporine In Takotsubo Syndrome | Phase II | rekrutiert |
| CytOSorb TreatMent Of Critically Ill PatientS Registry | — | rekrutiert |
| DERIVO® 2heal® Study: Clinical Safety and Efficacy of the DERIVO® 2heal® Embolisation Device | — | rekrutiert |
| DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrol | Phase III | rekrutiert |
| Dabrafenib and/or Trametinib Rollover Study | Phase IV | rekrutiert |
| De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcino | ohne Phasenangabe | rekrutiert |
| Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmon | Phase III | rekrutiert |
| Distrupt Stiffness Trial | ohne Phasenangabe | rekrutiert |
| Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature | — | rekrutiert |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in Peop | Phase III | rekrutiert |
| EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in N | Phase III | rekrutiert |
| Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody | Phase III | rekrutiert |
| Effects of the Clinical Application of Traditional, Complementary and Integrative Medicine (TCIM | — | rekrutiert |
| Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis | Phase II | rekrutiert |
| Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients | Phase II | rekrutiert |
| Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With | Phase III | rekrutiert |
| Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity o | Phase III | rekrutiert |
| Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight- | Phase III | rekrutiert |
| Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study | Phase III | rekrutiert |
| Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia ( | Phase III | rekrutiert |
| Efficacy and Safety of Zanubrutinib Plus Tislelizumab Treatment with or Without Sonrotoclax for | Phase II | rekrutiert |
| Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock | ohne Phasenangabe | rekrutiert |
| Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally | — | rekrutiert |
| Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular | Phase III | rekrutiert |
| Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to E | Phase III | rekrutiert |
| Endometrial Cancer Lymphadenectomy Trial | ohne Phasenangabe | rekrutiert |
| Endovascular Recanalization for Symptomatic Chronic Intradural Occlusions | — | rekrutiert |
| Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial | ohne Phasenangabe | rekrutiert |
| Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-c | — | rekrutiert |
| Essen Amyloidosis Registry | — | rekrutiert |
| Essen Coronary Artery Disease Registry | — | rekrutiert |
| Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in | — | rekrutiert |
| European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted | — | rekrutiert |
| European Newborn Study: Early Markers for a Better LifE | — | rekrutiert |
| Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With | Phase II | rekrutiert |
| Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With | Phase III | rekrutiert |
| Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intra | Phase II / Phase III | rekrutiert |
| Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Pat | Phase III | rekrutiert |
| Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer | Phase I | rekrutiert |
| FAPI-PET for Tumor Detection | — | rekrutiert |
| FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab i | Phase II / Phase III | rekrutiert |
| Feasibility of a Lifestyle Intervention for Women With Triple-negative Breast Cancer Under Neoad | ohne Phasenangabe | rekrutiert |
| Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FL | Phase II | rekrutiert |
| First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma | Phase I / Phase II | rekrutiert |
| Functionality of Albumin in the Context of Hemodialysis | ohne Phasenangabe | rekrutiert |
| Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor | Phase II | rekrutiert |
| GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological | — | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| GMMG Multiple Myeloma Registry | — | rekrutiert |
| Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITIO | Phase II | rekrutiert |
| German Cardiac Arrest Registry | — | rekrutiert |
| German Dementia Registry | — | rekrutiert |
| Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study | Phase II / Phase III | rekrutiert |
| HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory | Phase I / Phase II | rekrutiert |
| HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediat | Phase I / Phase II | rekrutiert |
| HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pedi | Phase I / Phase II | rekrutiert |
| HOPE Against Cancer Recurrence in HCC | Phase IV | rekrutiert |
| HRS-AKI Treatment With TIPS in Patients With Cirrhosis | ohne Phasenangabe | rekrutiert |
| Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Tre | — | rekrutiert |
| Health Effects of CArdiac FluoRoscopy and MOderN RadIotherapy in PediatriCs - Radiotherapy | — | rekrutiert |
| Hemodynamic Effects of Anesthesia Induction | — | rekrutiert |
| Hybrid Florbetaben PET/MRI for Imaging of Cardiac Amyloidosis | — | rekrutiert |
| Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy | ohne Phasenangabe | rekrutiert |
| IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors | Phase I / Phase II | rekrutiert |
| IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL | Phase III | rekrutiert |
| INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractor | Phase I / Phase II | rekrutiert |